Potential of 5-aza-2'-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer (Q43822201)

27 November 2017

Potential of 5-aza-2'-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer (English)

1 reference

27 November 2017

0 references

R L Momparler

1

1 reference

PubMed ID

11742714

27 November 2017

J Ayoub

series ordinal

2

1 reference

27 November 2017

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

34 Suppl 4

1 reference

27 November 2017

S111-5

1 reference

Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Cancer epigenetics comes of age

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

DNA methylation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Caspase 8: the killer you can't live without.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Methylation and silencing of the Thrombospondin-1 promoter in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Cellular differentiation, cytidine analogs and DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Preclinical antitumor activity of 5-aza-2'-deoxycytidine against human and neck cancer xenografts [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Clinical trial on 5-aza-2'-deoxycytidine in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

The DNA methylation machinery as a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Quantitation of inhibition of DNA methylation of the retinoic acid receptor beta gene by 5-Aza-2'-deoxycytidine in tumor cells using a single-nucleotide primer extension assay

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900397-X

7 January 2021

10.1016/S0169-5002(01)00397-X

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11742714